Page: Fees payable to the European Medicines Agency: Fees, charges and remuneration for assessment procedures and services relating to medicinal products for human use-2025/7/10

Page: Fees payable to the European Medicines Agency: Fees, charges and remuneration for assessment procedures and services relating to veterinary medicinal products-2025/7/10

Page: Fees payable to the European Medicines Agency: General questions and answers-2025/7/10

Page: Fees payable to the European Medicines Agency: Other fees and charges for medicinal products for human use, veterinary medicinal products and consultations on medical devices-2025/7/10

Document: New fee regulation: General questions and answers for all applicants-2025/7/10

Document: Annex II questions and answers – Fees, charges and remuneration for assessment procedures and services relating to veterinary medicinal products-2025/7/10

Document: Annex I questions and answers – Fees, charges and remuneration for assessment procedures and services relating to medicinal products for human use-2025/7/10

Document: Annex IV questions and answers – Other fees and charges for medicinal products for human use, veterinary medicinal products and consultations on medical devices-2025/7/10

Document: Dronedarone film-coated tablets 400 mg product-specific bioequivalence guidance - Revision 1-2025/7/10

Page: Dronedarone product-specific bioequivalence guidance-2025/7/10